PacBio narrows 2025 revenue guidance to $155M-$160M as consumables hit record and clinical focus intensifies
Source: SeekingAlpha
2025-11-05 21:42:21 ET
More on Pacific Biosciences of California
- Pacific Biosciences of California, Inc. (PACB) Q3 2025 Earnings Call Transcript
- Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- Pacific Biosciences of California, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Pacific Biosciences of California Non-GAAP EPS of -$0.12 beats by $0.02, revenue of $38.4M misses by $1.85M
- Pacific Biosciences of California Q3 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
PacBio narrows 2025 revenue guidance to $155M-$160M as consumables hit record and clinical focus intensifies
Pacific Biosciences of California Inc.
NASDAQ: PACB
PACB Trading
-2.83% G/L:
$1.375 Last:
1,981,899 Volume:
$1.38 Open:
PACB Latest News
March 05, 2026 08:30:00 am
PacBio Announces the Appointment of Chris Gibson to the Board of Directors
February 24, 2026 09:05:00 am
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
February 18, 2026 04:05:00 pm
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
PACB Stock Data
$549,471,524
294,359,745
0.64%
78
N/A
Biotechnology & Life Sciences
Healthcare
US
Menlo Park
